Anna M Eiring

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 23

Top Venues

International journal of molecular sciences

Clinical and translational medicine

Annals of cancer epidemiology

Leukemia

Texas Tech University Health Science Center El Paso Graduate School of Biomedical Sciences

The Ohio State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Texas Tech University Health Science Center El Paso Graduate School of Biomedical Sciences Jul 01 2018

United States

Assistant Professor :: Molecular and Translational Medicine

Huntsman Cancer Institute

United States

Postdoctoral Fellow

The Ohio State University

United States

Research Associate I :: Surgery

The Ohio State University

United States

Research Assistant II :: Surgery

Education History

The Ohio State University

United States

PHD

The Ohio State University

United States

BSC

Publications

Michelle Kilcoyne, Vutha Nhim, Mayra A Gonzalez, Idaly M Olivas, Anna M Eiring
Facility type and cancer outcomes in the United States. Annals of cancer epidemiology 7 (2023)
Michelle Kilcoyne, Vutha Nhim, Mayra A Gonzalez, Idaly M Olivas, Anna M Eiring
Facility type and cancer outcomes in the United States. Annals of cancer epidemiology 7 (2023)
Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Idaly M Olivas, James E Young, Jose L Lopez, Vanessa V Velazquez, Steven Glovier, Mehrshad Keivan, Andres J Rubio, Sara K Dang, Jonathan P Solecki, Jesse C Allen, Desiree N Tapia, Boranai Tychhon, Gonzalo E Astudillo, Connor Jordan, Darshan S Chandrashekar, Anna M Eiring
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International journal of molecular sciences 23 (23) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon, Anna M Eiring, Shrikanth S Gadad
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics. Vaccines 10 (5) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Idaly M Olivas, James E Young, Jose L Lopez, Vanessa V Velazquez, Steven Glovier, Mehrshad Keivan, Andres J Rubio, Sara K Dang, Jonathan P Solecki, Jesse C Allen, Desiree N Tapia, Boranai Tychhon, Gonzalo E Astudillo, Connor Jordan, Darshan S Chandrashekar, Anna M Eiring
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International journal of molecular sciences 23 (23) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Idaly M Olivas, James E Young, Jose L Lopez, Vanessa V Velazquez, Steven Glovier, Mehrshad Keivan, Andres J Rubio, Sara K Dang, Jonathan P Solecki, Jesse C Allen, Desiree N Tapia, Boranai Tychhon, Gonzalo E Astudillo, Connor Jordan, Darshan S Chandrashekar, Anna M Eiring
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International journal of molecular sciences 23 (23) (2022)
Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Idaly M Olivas, James E Young, Jose L Lopez, Vanessa V Velazquez, Steven Glovier, Mehrshad Keivan, Andres J Rubio, Sara K Dang, Jonathan P Solecki, Jesse C Allen, Desiree N Tapia, Boranai Tychhon, Gonzalo E Astudillo, Connor Jordan, Darshan S Chandrashekar, Anna M Eiring
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International journal of molecular sciences 23 (23) (2022)
Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Idaly M Olivas, James E Young, Jose L Lopez, Vanessa V Velazquez, Steven Glovier, Mehrshad Keivan, Andres J Rubio, Sara K Dang, Jonathan P Solecki, Jesse C Allen, Desiree N Tapia, Boranai Tychhon, Gonzalo E Astudillo, Connor Jordan, Darshan S Chandrashekar, Anna M Eiring
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International journal of molecular sciences 23 (23) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Alfonso E Bencomo-Alvarez, Andres J Rubio, Mayra A Gonzalez, Anna M Eiring
Blood cancer health disparities in the United States Hispanic population. Cold Spring Harbor molecular case studies 7 (2) (2021)
Andres J Rubio, Alfonso E Bencomo-Alvarez, James E Young, Vanessa V Velazquez, Joshua J Lara, Mayra A Gonzalez, Anna M Eiring
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy. Cells 10 (9) (2021)
Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Peyman Beigi, Mohammad Kiani, Ali Allahgholipour, Negar Goudarzi, Jamshid S Khorashad, Anna M Eiring
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia. Cells 10 (11) (2021)
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, Mayra A Gonzalez, Rebecca Ellwood, Carme Ripoll Fiol, Christopher A Eide, Joshua J Lara, Christian Barreto-Vargas, Luis F Jave-Suarez, Georgios Nteliopoulos, Alistair G Reid, Dragana Milojkovic, Brian J Druker, Jane Apperley, Jamshid S Khorashad, Anna M Eiring
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B. Oncogene 40 (15) (2021)
Helong Zhao, Anthony D Pomicter, Anna M Eiring, Anca Franzini, Jonathan Ahmann, Jae-Yeon Hwang, Anna V Senina, Bret Helton, Siddharth M Iyer, Dongqing Yan, Jamshid S Khorashad, Matthew S Zabriskie, Anupriya Agarwal, Hannah M Redwine, Amber D Bowler, Phillip M Clair, Shannon K McWeeney, Brian J Druker, Jeffrey W Tyner, Derek L Stirewalt, Vivian G Oehler, Sooryanarayana Varambally, Kristofer C Berrett, Jeffrey M Vahrenkamp, Jason Gertz, Katherine E Varley, Jerald Radich, Michael W Deininger
MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia by Enhancing Common β Chain Cytokine Receptor Endocytosis. Blood (2021)
Sara Ribeiro, Anna M Eiring, Jamshid S Khorashad
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia. Cancers 13 (20) (2021)
Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Andres J Rubio, Idaly M Olivas, Joshua J Lara, Osvaldo Padilla, Attilio Orazi, Javier Corral, Alexander Philipovskiy, Sumit Gaur, Zuber D Mulla, Alok K Dwivedi, Anna M Eiring
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study. Cancer 127 (7) (2020)
Ami B Patel, Anthony D Pomicter, Dongqing Yan, Anna M Eiring, Orlando Antelope, Jonathan A Schumacher, Todd W Kelley, Srinivas K Tantravahi, Tibor J Kovacsovics, Paul J Shami, Thomas O'Hare, Michael W Deininger
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms. Leukemia 34 (11) (2020)
Hein Than, Anthony D Pomicter, Dongqing Yan, Larry P Beaver, Anna M Eiring, William L Heaton, Anna Senina, Phillip M Clair, Sharon Shacham, Clinton C Mason, Thomas O' Hare, Michael W Deininger
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells. Leukemia 34 (6) (2020)
Alfonso E Bencomo-Alvarez, Andres J Rubio, Mayra A Gonzalez, Anna M Eiring
Energy metabolism and drug response in myeloid leukaemic stem cells. British journal of haematology 186 (4) (2019)

Anna M Eiring.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna M Eiring